Clinical Trials Logo

Cardiovascular Insufficiency clinical trials

View clinical trials related to Cardiovascular Insufficiency.

Filter by:
  • None
  • Page 1

NCT ID: NCT05828407 Completed - Venous Congestion Clinical Trials

Fluid Challenge Impact in the Portal Vein Pulsatility Depending on the Fluid Responsivness Status

FLUID-REVENGE
Start date: July 10, 2023
Phase:
Study type: Observational

Portal vein pulsatility index is a marker of venous congestion evaluated by point of care ultrasound. It is associated with acute kidney injury, especially in critically ill patients. It may be considered as a dynamic marker. The investigators hypothesized that portal vein pulsatility index is higher after a fluid challenge only in patient without preload dependence in critically ill patients with cardiovascular insufficiency.

NCT ID: NCT04086953 Terminated - Clinical trials for Chronic Obstructive Pulmonary Disease

Validation of a Walk-Time Limit Test (WTLT) Derived From the 6-Minute Walk Test (6-MWT) in Patients With Chronic Cardiovascular or Respiratory Diseases

TTLM
Start date: February 20, 2020
Phase: N/A
Study type: Interventional

Many exercise tests are commonly used to evaluate the changes of exercise tolerance following rehabilitation programs in patients with chronic respiratory diseases. Among the tests (6-MWT, incremental test, ...), the literature seems to indicate that endurance time is the most responsive parameter for detecting and quantifying changes in exercise capacity following a rehabilitation program. Although its clinical interest is undeniable, the endurance shuttle walking test is rarely used because it requires the prior performance of two incremental shuttle walking tests to determine the walking speed imposed on the patient. In this protocol, we propose to test a Walk-Time Limit Test (WTLT) derived from the 6-minute walk test (6-MWT) and based on the average walking speed achieved in this test commonly used in the follow-up of patients with chronic diseases. TTLM validation would improve the functional assessment of patients with chronic diseases while limiting the number of exercise tests.

NCT ID: NCT03882580 Recruiting - Clinical trials for Cardiovascular Complication

Reporting, Evaluating, Preventing and Treating the Cardiotoxicity Induced by Anticancer Drugs During a Specific Cardio-oncology Consult and Follow up in Routine Care

NEOCARDIO
Start date: March 1, 2019
Phase:
Study type: Observational

Several Drugs used in routine care in oncology induce rare but often severe or fatal cardiovascular or metabolic side effects. This study will investigate, evaluate, report and treat the cardiovascular side effects of anticancer drugs, through a specific cardiovascular routine checkup and follow-up taking place in several Cardio-oncology programs throughout France. The different including centers will be: Assistance Publique - Hôpitaux de Paris (APHP.6: Pitié-Salpétrière, Saint Antoine and Tenon's hospitals, Paris, France).

NCT ID: NCT03454802 Completed - Clinical trials for Cardiovascular Insufficiency

Passive Leg Raising - an Important Diagnostic Manoeuvre

PLR-ANS
Start date: September 1, 2018
Phase: N/A
Study type: Interventional

The aim is to describe the physiological background for PLR and the interpretation of a PLR manoeuvre. The protocol entails the measurement of stroke volume (SV) at baseline (semirecumbent patient position), during PLR and after returning to semirecumbent position. Simultaneously blood pressure (BP), pulse rate (PR), pulse oximetric saturation (SpO2) and ECG are recorded. The procedure is performed in ten normal subjects, ten patients recruited in the cardiology outpatient department and ten critically ill patients under analgosedation in the ICU. Analysis includes changes in measured variables and heart rate variability in the frequency domain during the three phases of the experiment.

NCT ID: NCT01954056 Completed - Clinical trials for Infant, Newborn, Diseases

Hydrocortisone for Term Hypotension

Start date: June 19, 2014
Phase: Phase 3
Study type: Interventional

This trial will evaluate the effects of a 7-day course of hydrocortisone therapy on short-term morbidity, cardiovascular function, long-term neurodevelopment, and mortality in critically ill, term and late preterm infants diagnosed with cardiovascular insufficiency as defined by a need for inotrope therapy in the first 72 hours of age.